Significant Accounting Policies [Text Block] | ( 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of business and basis of presentation National Research Corporation, doing business as NRC Health (“NRC Health,” the “Company,” “we,” “our,” “us” or similar terms), is a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Our purpose is to humanize healthcare and support organizations in their understanding of each person they serve not Our condensed consolidated balance sheet at December 31, 2023 Information and footnote disclosures included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto that are included in our Form 10 December 31, 2023, February 27, 2024. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated financial statements include the accounts of the Company and our wholly-owned subsidiary, National Research Corporation Canada. All significant intercompany transactions and balances have been eliminated. Our Canadian subsidiary used Canadian dollars as its functional currency. We translated its assets and liabilities into U.S. dollars at the exchange rate in effect at the balance sheet date. We translated its revenue and expenses at the average exchange rate during the period. During December 2022, three June 30, 2024 Revenue Recognition We derive a majority of our revenues from our annually renewable subscription-based service agreements with our customers, which include performance measurement and improvement services, healthcare analytics and governance education services. Such agreements are generally cancelable on short or no 2 ● Identify the contract, or contracts, with a customer; ● Identify the performance obligations in the contract; ● Determine the transaction price; ● Allocate the transaction price to the identified performance obligations; and ● Recognize revenue when, or as, we satisfy the performance obligations. Our revenue arrangements with a client may one may one one not not Our arrangements with customers consist principally of four 1 2 one 3 4 Subscription-based services - twelve may One-time services one Fixed, non-subscription services Unit-price services Revenue is presented net of any sales tax charged to our clients that we are required to remit to taxing authorities. We recognize contract assets or unbilled receivables related to revenue recognized for services completed but not Deferred Contract Costs Deferred contract costs, net is stated at gross deferred costs less accumulated amortization. We defer commissions and incentives, including payroll taxes, and certain implementation costs if they are incremental and recoverable costs of obtaining a renewable customer contract. Deferred contract costs are amortized over the estimated term of the contract, including renewals, which generally ranges from three five one three June 30, 2024 2023, six June 30, 2024 2023, June 30, 2024 December 31, 2023, June 30, 2024 2023 Three months ended Three months ended Six months ended Six months ended (In thousands) Direct Expenses $ 31 $ 43 $ 98 $ 78 Selling, general and administrative expenses 224 312 436 638 Total amortization $ 255 $ 355 $ 534 $ 716 Additional expense included in selling, general and administrative expenses for impairment of costs capitalized due to lost clients was $7,000 for the three June 30, 2023 six June 30, 2024 2023, three June 30, 2024. Trade Accounts Receivable Trade accounts receivable are recorded at the invoiced amount. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable, determined based on our historical write-off experience, current economic conditions and reasonable and supportable forecasts about the future. We review the allowance for doubtful accounts monthly. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The following table provides the activity in the allowance for doubtful accounts for the six June 30, 2024 2023 Balance at Beginning of Period Bad Debt Expense (Benefit) Write-offs Recoveries Balance at End of Period Six months ended June 30, 2024 $ 75 $ (65 ) $ 9 $ 49 $ 50 Six months ended June 30, 2023 $ 65 $ 113 $ 81 $ 3 $ 100 Leases We determine whether a lease is included in an agreement at inception. We recognize a lease liability and a right-of-use (“ROU”) asset on the balance sheet for our operating leases under which we are lessee. Operating lease ROU assets are included in operating lease right-of-use assets in our condensed consolidated balance sheet. Finance lease assets are included in property and equipment. Operating and finance lease liabilities are included in other current liabilities and other long-term liabilities. Certain lease arrangements may not ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments during the lease term. ROU assets and lease liabilities are recorded at lease commencement based on the estimated present value of lease payments. Because the rate of interest implicit in each lease is not Due to remote working arrangements, we reassessed our office needs and subleased our Seattle location under an agreement considered to be an operating lease beginning in May 2021. not Fair Value Measurements Our valuation techniques are based on maximizing observable inputs and minimizing the use of unobservable inputs when measuring fair value. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect our market assumptions. The inputs are then classified into the following hierarchy: ( 1 1 2 2 1 not 3 3 The following details our financial assets within the fair value hierarchy at June 30, 2024 December 31, 2023: Level 1 Level 2 Level 3 Total (In thousands) As of June 30, 2024 Money Market Funds $ 332 $ - $ - $ 332 Total Cash Equivalents $ 332 $ - $ - $ 332 As of December 31, 2023 Money Market Funds $ 6,471 $ - $ - $ 6,471 Total Cash Equivalents $ 6,471 $ - $ - $ 6,471 There were no six June 30, 2024. Our long-term debt described in Note 4 2 The following are the carrying amount and estimated fair values of long-term debt: June 30, December 31, 2023 (In thousands) Total carrying amount of long-term debt $ 33,305 $ 36,787 Estimated fair value of long-term debt $ 32,890 $ 36,403 The carrying amounts of accounts receivable, line of credit, accounts payable, and accrued expenses approximate their fair value. All non-financial assets that are not June 30, 2024 December 31, 2023, Annually, we consider whether the recorded goodwill and indefinite lived intangibles have been impaired. However, goodwill and intangibles must be tested between annual tests if an event occurs or circumstances change to indicate that it is more likely than not Commitments and Contingencies not June 30, 2024 |